23-valent Pneumococcal Polysaccharide Vaccine (23vPS)

BIOLOGICAL2 trials

Sponsors

Pfizer

Conditions

HIV InfectionsPneumococcal Infections

Phase 3

Study Comparing a 13-valent Pneumococcal Conjugate Vaccine With 23-valent Pneumococcal Polysaccharide Vaccine in Adults

CompletedNCT00427895

PfizerPneumococcal Infections

Start: 2007-02-27End: 2011-08-01Updated: 2021-11-15

Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in HIV-Infected Subjects 6 Years of Age or Older Who Are Naive to Pneumococcal Vaccine

CompletedNCT00962780

PfizerHIV Infections, Pneumococcal Infections

Start: 2010-03-31End: 2013-04-30Updated: 2014-11-17